- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 209.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 208.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 201.07M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $25.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $28.37M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.04M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $902.91K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $621.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $842.01M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $881.7M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $864.37M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $147.86M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $93.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $632.74M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $569.89M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $59.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $62.07M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.25B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.41B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $1.51B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.44M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.62M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$220.59M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.11M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$141.83M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $22.36M |
| Revenue | Q1 2026 · Mar 31, 2026 | $73.67M |
| Revenue | Q1 2026 · Mar 31, 2025 | $79.09M |